Key words: aortic aneurysm, pararenal aortic aneurysm, thoracoabdominal aortic aneurysm, aortic arch, endovascular aneurysm repair, renal artery, superficial mesenteric artery, celiac trunk, target vessel, stent-graft, side branch, chimney graft, periscope graft, parallel graft, target vessel patency, endoleak, side branch occlusionR enal artery stent placement to rescue an inadvertently covered renal artery orifice during aortic stent-graft deployment is a well-known bailout technique first reported by Greenberg et al. 1 and Larzon and colleagues. 2 Later, the term ''chimney graft'' was proposed when covered stents were deployed for this purpose. 3 More recently, the ''periscope graft'' technique was described, 4 which See commentary page 606 is similar to the chimney technique but in reverse fashion to extend the distal stent-graft landing zone. Use of chimney and periscope grafts was also reported to treat ruptured thoracoabdominal aortic aneurysms (TAAA) successfully. 5, 6 The majority of the published case series present the short-term results of small groups of patients treated with a single bare metal or covered stent placed as a chimney graft. 7 The aim of the present article is to report our ongoing experience with 77 consecutive patients treated over a 10-year period with renovisceral chimney and/or periscope grafts (CPGs).
METHODS

Study Cohort
From June 2002 to August 2012, 77 consecutive high-risk patients (62 men; mean age 7369 years) with aortic aneurysms extending to or involving the visceral aorta were treated with aortic stent-graft implantation and CPGs. All patients were considered at high risk for open aortic surgery and/or a standard renovisceral debranching procedure. 8 Fourteen were !80 years old. Patient morbidity included coronary artery or valvular heart disease and/or a left ventricular ejection fraction ,25%, chronic obstructive pulmonary disease, a hostile chest or abdomen (after prior abdominal or aortic surgery), and reduced renal function (Table 1 ). More than half (48, 62%) presented with multiple comorbidities. Mean glomerular filtration rate (GFR) at baseline was 54610 mL/min/1.73 m 2 . Nine patients were treated for a ruptured aneurysm and 12 for a symptomatic aneurysm. Mean aneurysm diameter was 70623 mm (range 44-185). Fifty-five (71.4%) patients presented with a pararenal aortic aneurysm, 16 (20.8%) patients with a TAAA, and 6 (7.8%) patients with an arch to visceral aortic aneurysm.
A preoperative thoracoabdominal computed tomographic angiography (CTA) was performed in all patients to assess anatomical details, plan the operative strategy, and measure maximum aneurysm diameter perpendicular to the flow line. 9 CPGs were planned in advance in all patients and were not used as a bailout after unintentional coverage of an aortic branch.
Patient imaging data, physiological parameters, and outcome data were collected prospectively in the clinical information system (Dendrite and KISIM UK) of our institution and analyzed retrospectively in February 2013. Informed consent for the procedure itself and the anonymous data collection and analysis was obtained from all patients. Early data on some of these patients (35 10 and 26 11 ) have been published as part of dual institution reports.
Technique
All procedures were performed in an angiography suite equipped for surgical interventions or a hybrid operating room with the patients under local (n¼22) or general (n¼55) anesthesia. Based on the anatomy of the aortic aneurysm and the renovisceral target arteries, a tailored approach for each patient was predefined on the basis of the CTA. In case of multiple CPGs, both axillary and femoral accesses were required to address the target vessels ( Fig. 1 ).
Five commercially available stent-grafts [Excluder and TAG (W.L. Gore & Associates, Flagstaff, AZ, USA); Evita (Jotec, Hechingen, Germany); Talent (Medtronic Vascular, Santa Rosa, CA, USA); and Zenith (Cook Inc., Bloomington, IN, USA)] were employed and tailored according to the CTA data. Diameter sizing of the aortic stent-graft was based on the mean aortic diameter and the mean diameter of the CPGs. For 2 CPGs, the mean diameter of the CPGs was added to the mean diameter of the aortic neck at the graft fixation site. If 3 CPGs were used, 1.53 the mean diameter of each CPG was added to the mean aortic diameter.
Remote access for aortic stent-graft introduction/deployment was mostly via the femoral artery and, in some rare cases, the aorta or iliac artery. Renovisceral branch cannulation was generally achieved using a 45-cm Arrow sheath (Arrow International Inc., Reading, PA, USA), a 5-F Chuang visceral reverse curve catheter (Cook Inc.), and a Rosen wire (Cook Inc.). The same procedure was repeated for each renovisceral branch. After cannulation, the chimney or periscope graft was positioned in the target artery and deployed with the distal end~2 cm into the target vessel. These parallel grafts were mostly the Viabahn (W.L. Gore & Associates); sometimes bare metal stents were used [Wallstent (Bos-ton Scientific Corporation, Natick, MA, USA) and Palmaz Blue or Corinthian SES (Cordis Endovascular/Johnson & Johnson, Miami, FL, USA)]. To achieve safe anchoring, angioplasty balloons (2 cm in length) were used to fully expand the CPGs at their anchoring/landing zone. The deflated balloons remained in the target arteries in order to prevent the CPGs from crossing over each other at the level of the aortic stent-graft landing zone. During deployment of the CPGs, the balloons were inflated in the target vessels and pullback traction was applied on the balloon catheters to keep the branch endografts straight while deploying the aortic stent-graft. A kissing balloon technique completed the procedure by achieving full and simultaneous expansion of all the different stent-grafts used, i.e., aortic, periscope, and chimney. In a ruptured Crawford II TAAA, the renal periscope endografts were deployed using a sandwich technique. 12 Once all devices were implanted, completion angiography, as well as selective pressure measurements distal to the aortic and any branch devices, was performed to exclude endoleaks and/or significant pressure gradients. Any significant high-flow type I or III endoleak detected during contrast injection was corrected immediately. In case of a significant pressure drop in a target vessel, additional kissing balloon inflation and/or bare metal stenting were performed.
Immediately after the procedure, duplex sonography was performed to confirm physiological perfusion of the abdominal organs and the absence of significant iliofemoral flow obstruction. A CTA was performed before hospital discharge in all patients. Any significant high-flow type I, II, or III endoleak filling whole or part of the aneurysm sac in the arterial phase of the CTA was corrected. Lowflow type I endoleaks emerging only during late-phase CTA and low-flow type II endoleaks were managed conservatively. 10 
Follow-up Protocol
Perioperative antiplatelet therapy (100 mg/d aspirin) combined with full heparinization was administered. Before discharge, patients were switched to aspirin and an oral anticoagulant for at least 3 months or to a dual antiplatelet regimen (aspirin and clopidogrel). A standardized follow-up protocol including CTA, laboratory testing, and clinical examination was performed at 6 weeks; 3, 6, and 12 months; and annually thereafter. Postoperative CTA was employed to assess changes in aneurysm diameter. 9 If there was a contraindication to contrast agent injection, a non-contrast CT and a duplex ultrasound of the aorta and target vessels were performed.
RESULTS
The aortic aneurysms were treated with 46 bifurcated, 30 straight, and 1 aortouni-iliac stent-graft configurations using a mean of 3 stent-grafts (median 2, range 1-5) in each patient. The mean diameter of the stent-grafts was 32.064.5 mm (range 23-46), while the mean aortic diameter neck was 28.264.4 mm (range [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] .
Immediate technical success (procedure completed as intended) was achieved in 76 (99%) patients (Fig. 2) . In one obese patient (body mass index 41 kg/m 2 ) presenting with a ruptured pararenal aneurysm, a branch stentgraft became dislocated from the right renal artery. This artery could not be re-accessed, and the right kidney was sacrificed.
Overall, 169 target vessels (121 renal arteries, 30 superior mesenteric arteries, 17 celiac trunks, and 1 inferior mesenteric artery) were addressed using the chimney graft configuration in 111 and the periscope graft configuration in 58. In total, 228 devices were employed to construct the CPGs: 213 Viabahn stent- grafts and 15 bare metal stents (mean 1.35/ vessel; 2.19/patient). Table 2 describes the CPG configuration and devices used with respect to the location. The mean procedure time, including surgical access and skin closure, was 2486104 minutes (range 90-390) with a mean radiation dose area product of 45494629022 mGy*cm 2 (range 14473-97899).
The mean lengths of stay were 2.264.1 days in intensive care and 14620 days in hospital. One patient with a ruptured pararenal aneurysm died from reperfusion injury and multiple organ failure on the 9 th postoperative day. Another patient with a ruptured pararenal aneurysm died on the 7 th postoperative day from multiorgan failure. Perioperative major complications included a renal hematoma in 3 patients and a psoas hematoma due to an iliac rupture. The renal hematomas were treated conservatively; the iliac rupture was excluded with the bifurcated stent-graft during the initial endovascular repair. Perioperative access site complications included 2 left axillary hematomas treated with surgical evacuation and a bilateral lymphatic fistula treated with vacuum-assisted closure therapy.
At postoperative CTA, 19 patients had primary type I [16 Ia and 3 Ib ( Fig. 3) ] endoleaks, 1 patient had a type III endoleak, and 14 patients had type II leaks (2 patients presented both types Ia and II). At a mean follow-up of 25.5616.0 months (range 1-121), 3 of the 20 primary type I/III endoleaks were still present, but no secondary or recurrent endoleaks were noted. Additional endovascu-lar maneuvers (Fig. 4) were required for CPGrelated complications in 13 patients from intervention throughout follow-up; in 1 case this procedure was planned intraoperatively.
Mean aortic aneurysm diameter at followup decreased by 13.3%620.0% to 61.1 mm (range 30-160). In 4 (5.2%) patients, an increase in the aneurysm diameter was observed; one of these patients had a type Ia endoleak, and an endovascular perigraft embolization is planned.
During follow-up, no statistically significant difference was observed in renal function (mean GFR 56.2611.0 mL/min/1.72 m 2 ). Over the course of the study period, 9 patients died of unrelated causes (actuarial patient survival is presented in Figure 5A ). From intervention onward, 4 CPGs occluded (98% target vessel patency), all within 30 days. The Kaplan-Meier freedom from occlusion estimate is presented in Figure 5B .
DISCUSSION
Open graft repair of pararenal, thoracoabdominal, and aortic aneurysms generally has a substantial operative mortality and morbidity. 1, 13 Endovascular repair with fenestrated and/or branched stent-grafts is an attractive alternative to open repair, but has significant limitations. Although some have reported successful use of surgeon-made fenestrated and branched endografts, 14 the commercial devices generally have to be customized, which excludes urgent or emergent patients. In addition, some patients are unsuitable forT ontinuous data are presented as the means 6 standard deviation; categorical data are given as the counts. RRA: right renal artery, LRA: left renal artery, SMA: superior mesenteric artery, CT: celiac trunk, IMA: inferior mesenteric artery. any of these devices. 15, 16 On the other hand, CPGs are an alternative way of treating these complex aneurysms and allow the use of offthe-shelf devices to treat emergency cases, patients unfit for thoracoabdominal open surgery, or patients who are not suitable for branched or fenestrated stent-grafts due to anatomical restrictions. 10, [16] [17] [18] [19] [20] CPGs have some major advantages over the branched graft techniques. For each aortic branch, the best branch design, chimney or periscope, can be chosen specifically based on the target vessel, the remote access vessel, and the aortic anatomy so that the procedure can be performed without delay. In addition, navigation and/or manipulations are greatly simplified as the wires, catheters, and parallel stent-grafts do not have to be directed through the aortic stent-graft. An additional advantage of the CPGs is that they minimize secondary stent-graft dislocation out of the aortic branch, as the CPGs are fixed inbetween the aortic wall and the aortic stentgraft.
Endoleaks have been reported in association with CPGs. 20 We differentiate two types of primary endoleaks: ''high-flow,'' which appear immediately after contrast injection, vs. ''low-flow,'' which appear after some delay. We treat all primary and secondary high-flow types Ia and Ib leaks but tend to observe low-flow ones. 10 Even in patients with ruptured aneurysms and low-flow leaks, we have observed that hemorrhage is effectively controlled. Moreover, low-flow leaks encountered in patients with severely disturbed coagulation usually disappear once the coagulation system normalizes. Using covered stent-grafts (such as the Viabahn) for the periscope or chimney grafts usually prevents a type I/III endoleak.
To avoid high-flow type I leaks along the CPGs gutters, we have developed and used a method to adequately size the aortic stentgraft. Adding half of the mean diameter of all the CPGs used to the mean aortic diameter leads to adequate main stent-graft redundancy to fully cover all the CPGs. The overlap length between the CPGs and the main aortic graft is another important issue. To achieve adequate sealing between the CPGs, the main aortic graft, and the aortic wall, an overlap of 4 cm is required to minimize type I endoleaks and gutters, although this may not always be anatomically feasible.
However, there are some general limitations to this technique. For the construction of CPGs, access through the subclavian artery and the aortic arch has to be safe. Any floating plaques or arch disease in the region of the supra-aortic trunks carries a high stroke risk and represent a contraindication to placement of CPGs from above. There are, however, methods to approach visceral arteries from the femoral arteries to get a chimney configuration. 21 In addition, some degree of branch disease can be accepted with this technique, but the target artery should not have major disease and should have a minimal diameter of .4 mm and a safe landing zone of .1 cm. In addition, the CPG technique requires highend imaging tools. Especially with multiple CPGs, clear visualization of catheters, wires, sheaths, and grafts is essential, and standard portable C-arm fluoroscopy may not be adequate. Finally, although the present midterm results, along with other reports, 11 are encouraging and suggest that CPGs are a Figure 5^ (A) Cumulative survival of patients treated with chimney and/or periscopes grafts and (B) freedom from occlusion for the parallel grafts. Standard error did not exceed 10% at 36 months. durable way of revascularizing renovisceral aortic branches involved in aneurysmal disease, the overall experience with CPGs is limited, and long-term follow-up is needed to document the durability of these techniques.
Conclusion
In this series, the use of CPGs has proven to be a feasible, safe, and effective way to treat thoracoabdominal and pararenal aneurysms with maintenance of blood flow to the renovisceral arteries. Nearly all of the aneurysms showed no increase in diameter and a 13% average aneurysm diameter reduction over a mean .2-year follow-up, which supports the midterm adequacy of the CPG technique as a method to effectively revascularize branch vessels with few endoleaks or branch occlusions. Thus, provided certain technical requirements are fulfilled, these techniques appear to be justified when patients are at high risk for other methods of repair or have complex ruptured aneurysms involving vital aortic branch arteries.
